BISOPROLOL FUMARATE

BISOPROLOL FUMARATE was reported 137658 times

BISOPROLOL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 409 0.7330
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 111 0.6201
2 IMMUNISATION 266 0.6129
3 PALMOPLANTAR KERATODERMA 401 0.5531
4 NEUROLOGIC NEGLECT SYNDROME 206 0.3705
5 VITAL CAPACITY DECREASED 125 0.2790
6 CAROTID ARTERY THROMBOSIS 211 0.2485
7 AMAUROSIS FUGAX 267 0.2479
8 ATRIAL TACHYCARDIA 509 0.2422
9 SYSTEMIC INFECTION 338 0.2037
10 REVERSIBLE AIRWAYS OBSTRUCTION 103 0.2028
11 PRURITUS GENITAL 437 0.1854
12 STEROID DEPENDENCE 147 0.1674
13 CATARRH 149 0.1648
14 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 221 0.1573
15 BRONCHIAL SECRETION RETENTION 198 0.1554
16 ADJUSTMENT DISORDER 196 0.1508
17 BRONCHIAL WALL THICKENING 96 0.1335
18 PRODUCT MONITORING ERROR 191 0.1322
19 SPUTUM CULTURE POSITIVE 104 0.1281
20 CARDIAC FAILURE CHRONIC 521 0.1221
21 BRADYARRHYTHMIA 198 0.1204
22 CAROTID ARTERIOSCLEROSIS 124 0.1202
23 CAROTID ARTERY OCCLUSION 438 0.1199
24 MYOGLOBIN BLOOD INCREASED 164 0.1072
25 AORTIC VALVE STENOSIS 188 0.1053
26 RIGHT VENTRICULAR HYPERTROPHY 95 0.1052
27 TENSION HEADACHE 436 0.1013
28 OBSTRUCTIVE SLEEP APNOEA SYNDROME 147 0.1008
29 SYSTOLIC DYSFUNCTION 104 0.0987
30 PULMONARY FUNCTION TEST ABNORMAL 153 0.0981
31 SLEEP TERROR 405 0.0961
32 BLOODY DISCHARGE 108 0.0945
33 DIASTOLIC DYSFUNCTION 285 0.0922
34 BRAIN NATRIURETIC PEPTIDE INCREASED 279 0.0904
35 INTERNATIONAL NORMALISED RATIO FLUCTUATION 186 0.0898
36 LEFT VENTRICULAR DYSFUNCTION 602 0.0898
37 SINUS NODE DYSFUNCTION 158 0.0862
38 TACHYARRHYTHMIA 209 0.0837
39 BURNS SECOND DEGREE 146 0.0831
40 PERSONALITY DISORDER 218 0.0831
41 VENTRICULAR HYPOKINESIA 265 0.0824
42 ATRIOVENTRICULAR BLOCK COMPLETE 547 0.0816
43 MONOPARESIS 143 0.0790
44 BRASH SYNDROME 110 0.0783
45 HAEMATOMA MUSCLE 93 0.0776
46 DYSPNOEA AT REST 224 0.0772
47 SUBARACHNOID HAEMORRHAGE 745 0.0731
48 ORTHOPNOEA 231 0.0725
49 CARDIOACTIVE DRUG LEVEL INCREASED 95 0.0722
50 CORONARY ARTERY STENOSIS 342 0.0679
51 HYPERKALAEMIA 2371 0.0675
52 SINUS BRADYCARDIA 650 0.0672
53 MITRAL VALVE INCOMPETENCE 752 0.0664
54 WRONG PATIENT RECEIVED PRODUCT 193 0.0659
55 VENTRICULAR TACHYCARDIA 1089 0.0659
56 BLOOD PRESSURE SYSTOLIC ABNORMAL 161 0.0651
57 BRADYCARDIA 3449 0.0650
58 RALES 376 0.0647
59 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 546 0.0617
60 ISCHAEMIC CARDIOMYOPATHY 186 0.0606
61 HYPOMAGNESAEMIA 832 0.0597
62 ATRIOVENTRICULAR BLOCK 455 0.0588
63 URINARY TRACT DISORDER 259 0.0575
64 VASOPLEGIA SYNDROME 94 0.0573
65 BLOOD PRESSURE DIASTOLIC ABNORMAL 145 0.0570
66 VASCULAR STENT THROMBOSIS 116 0.0569
67 ATRIAL FLUTTER 450 0.0563
68 HAEMORRHAGIC STROKE 439 0.0562
69 LEFT VENTRICULAR FAILURE 192 0.0557
70 BUNDLE BRANCH BLOCK LEFT 236 0.0556
71 VENTRICULAR ARRHYTHMIA 203 0.0554
72 BRONCHIECTASIS 371 0.0550
73 LEFT VENTRICULAR HYPERTROPHY 233 0.0544
74 SHOCK HAEMORRHAGIC 436 0.0535
75 CONGESTIVE CARDIOMYOPATHY 221 0.0530
76 FACIAL PAIN 468 0.0524
77 MICROCYTIC ANAEMIA 109 0.0524
78 MELAENA 1149 0.0522
79 DUODENAL ULCER HAEMORRHAGE 149 0.0520
80 BLOOD PRESSURE SYSTOLIC DECREASED 234 0.0514
81 ATRIOVENTRICULAR BLOCK SECOND DEGREE 156 0.0514
82 HYPOPNOEA 178 0.0512
83 ATRIAL THROMBOSIS 106 0.0512
84 CARDIAC FAILURE ACUTE 341 0.0511
85 ORTHOSTATIC HYPOTENSION 885 0.0508
86 AORTIC ARTERIOSCLEROSIS 129 0.0501
87 VASCULITIS 583 0.0500
88 ANAEMIA MACROCYTIC 106 0.0496
89 POTENTIATING DRUG INTERACTION 166 0.0494
90 EJECTION FRACTION DECREASED 767 0.0493
91 CARDIAC FAILURE 3931 0.0489
92 BREATH SOUNDS ABNORMAL 239 0.0484
93 ACUTE KIDNEY INJURY 7415 0.0484
94 CEREBRAL HAEMATOMA 162 0.0482
95 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 195 0.0477
96 TRICUSPID VALVE INCOMPETENCE 379 0.0477
97 BENIGN PROSTATIC HYPERPLASIA 246 0.0476
98 ERYSIPELAS 239 0.0475
99 ACUTE CORONARY SYNDROME 392 0.0473
100 DUODENITIS 145 0.0472
101 CARDIOGENIC SHOCK 676 0.0471
102 HYPONATRAEMIA 2644 0.0469
103 IRON DEFICIENCY 211 0.0469
104 OBSTRUCTIVE AIRWAYS DISORDER 519 0.0466
105 ABDOMINAL WALL HAEMATOMA 91 0.0466
106 COMA SCALE ABNORMAL 135 0.0466
107 ELECTROCARDIOGRAM ABNORMAL 365 0.0465
108 AORTIC VALVE INCOMPETENCE 197 0.0463
109 HYPERURICAEMIA 189 0.0459
110 PERICARDIAL HAEMORRHAGE 99 0.0452
111 BLOOD LOSS ANAEMIA 100 0.0441
112 ATRIAL FIBRILLATION 4294 0.0440
113 INTERNATIONAL NORMALISED RATIO INCREASED 1240 0.0434
114 ALCOHOL POISONING 115 0.0429
115 ANGINA PECTORIS 1223 0.0426
116 HEMIPLEGIA 349 0.0419
117 ELECTROLYTE IMBALANCE 487 0.0419
118 ATRIOVENTRICULAR BLOCK FIRST DEGREE 180 0.0415
119 LACTIC ACIDOSIS 1340 0.0413
120 PANNICULITIS 100 0.0413
121 EXERCISE TOLERANCE DECREASED 236 0.0410
122 GANGRENE 246 0.0408
123 AORTIC STENOSIS 141 0.0404
124 UPPER GASTROINTESTINAL HAEMORRHAGE 677 0.0402
125 CHEST X-RAY ABNORMAL 123 0.0401
126 GASTRITIS EROSIVE 187 0.0401
127 HYPERTENSIVE CRISIS 446 0.0401
128 HYPOVOLAEMIC SHOCK 192 0.0400
129 PLANTAR FASCIITIS 134 0.0399
130 DYSPNOEA EXERTIONAL 1457 0.0386
131 CAROTID ARTERY STENOSIS 135 0.0386
132 FOETAL GROWTH RESTRICTION 235 0.0386
133 RED CELL DISTRIBUTION WIDTH INCREASED 160 0.0385
134 BLOOD PRESSURE SYSTOLIC INCREASED 750 0.0384
135 PEMPHIGOID 288 0.0381
136 SENSORY LOSS 307 0.0381
137 EOSINOPHILIA 667 0.0380
138 ANURIA 325 0.0377
139 CIRCULATORY COLLAPSE 643 0.0377
140 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 387 0.0377
141 PRESYNCOPE 916 0.0376
142 TORSADE DE POINTES 293 0.0373
143 GLOMERULAR FILTRATION RATE DECREASED 458 0.0372
144 DRUG INTERACTION 5896 0.0371
145 BLOOD PRESSURE DIASTOLIC DECREASED 274 0.0371
146 SUPRAVENTRICULAR EXTRASYSTOLES 124 0.0367
147 RHEUMATOID NODULE 101 0.0366
148 INTRAVENTRICULAR HAEMORRHAGE 91 0.0365
149 HEMIPARESIS 616 0.0363
150 INFLAMMATORY MARKER INCREASED 180 0.0363
151 HAEMATOMA 938 0.0362
152 EMBOLIC STROKE 127 0.0360
153 HYPOKALAEMIA 1664 0.0360
154 ACUTE PULMONARY OEDEMA 202 0.0360
155 ARTERIAL OCCLUSIVE DISEASE 282 0.0358
156 EUGLYCAEMIC DIABETIC KETOACIDOSIS 148 0.0358
157 VENTRICULAR EXTRASYSTOLES 371 0.0357
158 ACUTE MYOCARDIAL INFARCTION 1050 0.0356
159 CARDIAC MURMUR 306 0.0353
160 DRUG TOLERANCE DECREASED 99 0.0352
161 RHABDOMYOLYSIS 1464 0.0351
162 HAEMATURIA 1200 0.0350
163 ISCHAEMIC STROKE 625 0.0350
164 ANGINA UNSTABLE 226 0.0347
165 SUBDURAL HAEMORRHAGE 95 0.0347
166 HAEMATEMESIS 873 0.0344
167 COLITIS MICROSCOPIC 162 0.0342
168 HEPATIC CYTOLYSIS 431 0.0338
169 ABNORMAL LOSS OF WEIGHT 229 0.0336
170 SMALL FOR DATES BABY 166 0.0334
171 SUBDURAL HAEMATOMA 478 0.0334
172 HYPOCALCAEMIA 630 0.0333
173 GENERAL PHYSICAL HEALTH DETERIORATION 3846 0.0332
174 DUODENAL ULCER 234 0.0331
175 PERICARDITIS 555 0.0330
176 LYME DISEASE 110 0.0330
177 ESCHERICHIA URINARY TRACT INFECTION 140 0.0329
178 MYOCARDIAL ISCHAEMIA 373 0.0327
179 SKIN NECROSIS 170 0.0327
180 RESPIRATORY ACIDOSIS 128 0.0325
181 BUNDLE BRANCH BLOCK RIGHT 149 0.0324
182 HAEMOTHORAX 94 0.0324
183 GENERALISED OEDEMA 400 0.0323
184 VITAMIN B12 DECREASED 93 0.0322
185 DIPLOPIA 838 0.0322
186 SOPOR 426 0.0321
187 DYSLIPIDAEMIA 163 0.0321
188 NORMOCHROMIC NORMOCYTIC ANAEMIA 96 0.0319
189 VENTRICULAR FIBRILLATION 354 0.0318
190 MYOPATHY 274 0.0317
191 UROSEPSIS 292 0.0316
192 PERIPHERAL ISCHAEMIA 129 0.0316
193 NEUTROPENIC SEPSIS 225 0.0315
194 ELECTROCARDIOGRAM QT PROLONGED 1130 0.0314
195 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 104 0.0314
196 MOTOR DYSFUNCTION 319 0.0313
197 OBSTRUCTION 125 0.0313
198 HEPATITIS CHOLESTATIC 187 0.0310
199 TONGUE OEDEMA 117 0.0306
200 MYOSITIS 274 0.0305
201 EXTRASYSTOLES 213 0.0305
202 BLOOD CREATINE INCREASED 135 0.0305
203 ANOSMIA 441 0.0304
204 JAUNDICE CHOLESTATIC 107 0.0303
205 MIXED LIVER INJURY 91 0.0302
206 ARRHYTHMIA 1430 0.0302
207 CHOLESTASIS 570 0.0297
208 POLYURIA 241 0.0294
209 EOSINOPHIL COUNT INCREASED 244 0.0292
210 BLOOD URIC ACID INCREASED 169 0.0292
211 SYNCOPE 2927 0.0292
212 TROPONIN INCREASED 222 0.0291
213 CUTANEOUS VASCULITIS 105 0.0287
214 CARDIAC DYSFUNCTION 107 0.0287
215 HYPOVOLAEMIA 168 0.0287
216 HYPERVOLAEMIA 141 0.0285
217 C-REACTIVE PROTEIN INCREASED 1038 0.0285
218 FULL BLOOD COUNT ABNORMAL 301 0.0284
219 HEART RATE DECREASED 999 0.0284
220 METABOLIC ACIDOSIS 907 0.0283
221 OLIGURIA 176 0.0283
222 BASAL CELL CARCINOMA 441 0.0282
223 INTERNATIONAL NORMALISED RATIO ABNORMAL 97 0.0282
224 AGRANULOCYTOSIS 522 0.0281
225 BODY TEMPERATURE DECREASED 276 0.0280
226 MONOCYTE COUNT INCREASED 101 0.0278
227 HYPOTENSION 5575 0.0278
228 ALTERED STATE OF CONSCIOUSNESS 601 0.0277
229 STRESS CARDIOMYOPATHY 161 0.0277
230 POLYNEUROPATHY 330 0.0275
231 FEMORAL NECK FRACTURE 141 0.0275
232 IRON DEFICIENCY ANAEMIA 249 0.0269
233 TRANSIENT ISCHAEMIC ATTACK 906 0.0268
234 DERMATITIS EXFOLIATIVE GENERALISED 93 0.0267
235 FAECALOMA 146 0.0266
236 MUSCLE SPASTICITY 325 0.0264
237 HAEMORRHAGIC DIATHESIS 94 0.0264
238 RHINITIS 212 0.0263
239 CEREBRAL ISCHAEMIA 135 0.0262
240 DERMATITIS EXFOLIATIVE 131 0.0262
241 CARDIOMEGALY 322 0.0262
242 RECTAL HAEMORRHAGE 1124 0.0261
243 FEBRILE BONE MARROW APLASIA 111 0.0261
244 TINNITUS 1194 0.0260
245 TACHYCARDIA 2303 0.0259
246 CORONARY ARTERY DISEASE 781 0.0258
247 RENAL FAILURE ACUTE 1091 0.0257
248 AFFECT LABILITY 245 0.0254
249 GAMMA-GLUTAMYLTRANSFERASE INCREASED 564 0.0254
250 LIP SWELLING 847 0.0254
251 HYPERTHYROIDISM 367 0.0253
252 TOXIC SKIN ERUPTION 255 0.0253
253 CREATININE RENAL CLEARANCE DECREASED 101 0.0252
254 PURPURA 223 0.0252
255 HYPOGLYCAEMIA 1212 0.0250
256 LOWER GASTROINTESTINAL HAEMORRHAGE 184 0.0249
257 RENAL IMPAIRMENT 2091 0.0249
258 HYPERNATRAEMIA 124 0.0249
259 MYOCARDITIS 285 0.0248
260 TACHYPNOEA 337 0.0248
261 SUPRAVENTRICULAR TACHYCARDIA 232 0.0242
262 NOCTURIA 294 0.0242
263 JAUNDICE 648 0.0241
264 PRODUCT PRESCRIBING ERROR 573 0.0240
265 DIVERTICULUM INTESTINAL 105 0.0240
266 TUBULOINTERSTITIAL NEPHRITIS 450 0.0240
267 INTESTINAL ISCHAEMIA 132 0.0239
268 RENAL CYST 190 0.0239
269 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 121 0.0239
270 BLOOD UREA INCREASED 400 0.0239
271 POISONING DELIBERATE 226 0.0238
272 CONCOMITANT DISEASE AGGRAVATED 147 0.0238
273 MUSCLE TWITCHING 544 0.0236
274 ENDOCARDITIS 121 0.0236
275 CLOSTRIDIUM DIFFICILE COLITIS 250 0.0236
276 BLOOD CREATININE INCREASED 1538 0.0235
277 BLOOD CREATINE PHOSPHOKINASE INCREASED 678 0.0235
278 ISCHAEMIA 108 0.0235
279 RENAL FUNCTION TEST ABNORMAL 109 0.0235
280 PULSELESS ELECTRICAL ACTIVITY 98 0.0234
281 OCULAR DISCOMFORT 262 0.0233
282 CARDIOMYOPATHY 344 0.0233
283 CARDIAC TAMPONADE 110 0.0231
284 LIVER FUNCTION TEST ABNORMAL 673 0.0231
285 URINE OUTPUT DECREASED 202 0.0231
286 TOXIC EPIDERMAL NECROLYSIS 350 0.0230
287 OEDEMA PERIPHERAL 2801 0.0230
288 INTERNATIONAL NORMALISED RATIO DECREASED 93 0.0229
289 DRUG LEVEL INCREASED 380 0.0229
290 ARTERIOSCLEROSIS CORONARY ARTERY 152 0.0229
291 MUSCLE HAEMORRHAGE 92 0.0229
292 RASH MACULO-PAPULAR 510 0.0229
293 HYPOTHERMIA 231 0.0228
294 BLOOD PRESSURE DIASTOLIC INCREASED 105 0.0227
295 CEREBRAL HAEMORRHAGE 813 0.0227
296 BLOOD PRESSURE FLUCTUATION 545 0.0227
297 COORDINATION ABNORMAL 316 0.0226
298 CEREBRAL INFARCTION 551 0.0225
299 CACHEXIA 116 0.0225
300 SKIN HAEMORRHAGE 334 0.0225
301 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 175 0.0225
302 CONTRAINDICATED PRODUCT ADMINISTERED 682 0.0225
303 DERMATITIS BULLOUS 163 0.0225
304 ANAEMIA 4270 0.0224
305 INTERSTITIAL LUNG DISEASE 1084 0.0224
306 ANGIOEDEMA 983 0.0222
307 COVID-19 PNEUMONIA 262 0.0222
308 GOUT 398 0.0222
309 RED BLOOD CELL SEDIMENTATION RATE INCREASED 245 0.0221
310 GUILLAIN-BARRE SYNDROME 107 0.0221
311 HEAD DISCOMFORT 391 0.0221
312 PAROSMIA 165 0.0218
313 LIPASE INCREASED 167 0.0218
314 HAEMORRHAGE INTRACRANIAL 324 0.0216
315 HEPATITIS ACUTE 140 0.0215
316 PANCYTOPENIA 1202 0.0215
317 STAPHYLOCOCCAL SEPSIS 106 0.0214
318 BLOOD LACTIC ACID INCREASED 113 0.0214
319 PLEURAL EFFUSION 1300 0.0213
320 HALLUCINATION, VISUAL 451 0.0213
321 HAEMATOCHEZIA 1177 0.0213
322 DYSARTHRIA 799 0.0212
323 PULMONARY FIBROSIS 407 0.0212
324 PALLOR 576 0.0211
325 CHOLANGITIS 131 0.0211
326 SINUS CONGESTION 285 0.0211
327 PROTHROMBIN TIME PROLONGED 126 0.0210
328 PERIPHERAL SENSORY NEUROPATHY 123 0.0210
329 PULMONARY OEDEMA 942 0.0210
330 ASCITES 618 0.0210
331 ACIDOSIS 159 0.0208
332 CONFUSIONAL STATE 3358 0.0208
333 HEART RATE IRREGULAR 469 0.0207
334 URINARY RETENTION 692 0.0207
335 GINGIVAL PAIN 165 0.0207
336 SHOCK 476 0.0207
337 SECRETION DISCHARGE 256 0.0204
338 HYPERCALCAEMIA 252 0.0204
339 ILEUS PARALYTIC 91 0.0204
340 PALPITATIONS 2384 0.0203
341 MULTIPLE ORGAN DYSFUNCTION SYNDROME 576 0.0203
342 APHASIA 613 0.0203
343 BLOOD POTASSIUM INCREASED 326 0.0201
344 PANCREATITIS ACUTE 451 0.0200
345 ATAXIA 238 0.0200
346 HEPATOCELLULAR INJURY 283 0.0199
347 PULMONARY CONGESTION 263 0.0199
348 SUDDEN DEATH 210 0.0198
349 DEHYDRATION 2638 0.0198
350 BLINDNESS 803 0.0197
351 RESPIRATORY TRACT INFECTION 512 0.0196
352 LARGE INTESTINE POLYP 136 0.0196
353 RIGHT VENTRICULAR FAILURE 137 0.0195
354 OESOPHAGITIS 212 0.0194
355 SEPTIC SHOCK 844 0.0194
356 VITAMIN D DEFICIENCY 188 0.0193
357 GASTROENTERITIS 281 0.0192
358 DELIRIUM 668 0.0192
359 HYPERBILIRUBINAEMIA 199 0.0192
360 HAEMODYNAMIC INSTABILITY 146 0.0191
361 PETECHIAE 198 0.0190
362 GASTRIC ULCER 359 0.0189
363 MYOCLONUS 224 0.0188
364 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 482 0.0187
365 FAECES SOFT 136 0.0187
366 COLITIS ISCHAEMIC 126 0.0187
367 ECCHYMOSIS 128 0.0187
368 RASH PAPULAR 418 0.0186
369 COGNITIVE DISORDER 870 0.0186
370 RESPIRATORY TRACT CONGESTION 294 0.0185
371 HYPERGLYCAEMIA 674 0.0185
372 PULMONARY HYPERTENSION 385 0.0185
373 SENSATION OF FOREIGN BODY 155 0.0184
374 THROMBOCYTOPENIA 2035 0.0182
375 FAECES DISCOLOURED 393 0.0181
376 DISORIENTATION 716 0.0181
377 PYELONEPHRITIS 156 0.0180
378 CHOLECYSTITIS ACUTE 102 0.0180
379 PERICARDIAL EFFUSION 416 0.0180
380 BLOOD PRESSURE DECREASED 1195 0.0180
381 MEDICATION ERROR 993 0.0178
382 COMA 846 0.0177
383 PAIN OF SKIN 478 0.0177
384 MUSCULAR WEAKNESS 2016 0.0177
385 GASTROINTESTINAL HAEMORRHAGE 1478 0.0177
386 RESPIRATORY RATE INCREASED 157 0.0177
387 SPUTUM DISCOLOURED 167 0.0176
388 SKIN ULCER 455 0.0176
389 MOUTH HAEMORRHAGE 129 0.0176
390 HEART RATE ABNORMAL 98 0.0176
391 HEPATITIS 448 0.0175
392 DRUG ERUPTION 310 0.0175
393 DISTURBANCE IN ATTENTION 940 0.0174
394 NECROSIS 97 0.0174
395 ARTERIOSCLEROSIS 164 0.0174
396 SPINAL OSTEOARTHRITIS 153 0.0174
397 TRANSAMINASES INCREASED 386 0.0173
398 MULTIPLE ALLERGIES 136 0.0173
399 HALLUCINATION 1303 0.0173
400 WHEEZING 1022 0.0172
401 HYPOPHOSPHATAEMIA 127 0.0172
402 HYPOKINESIA 249 0.0171
403 VERTIGO 1041 0.0171
404 PERIPHERAL COLDNESS 233 0.0170
405 RENAL FAILURE 2253 0.0170
406 SWOLLEN TONGUE 529 0.0169
407 HAEMOPTYSIS 472 0.0169
408 BLOOD PRESSURE INCREASED 2576 0.0168
409 CARDIO-RESPIRATORY ARREST 704 0.0168
410 AUTOIMMUNE HEPATITIS 117 0.0168
411 DIABETES MELLITUS INADEQUATE CONTROL 297 0.0168
412 HIATUS HERNIA 216 0.0167
413 PNEUMONIA ASPIRATION 416 0.0166
414 UPPER-AIRWAY COUGH SYNDROME 137 0.0166
415 LEUKOPENIA 829 0.0166
416 HYPERTRANSAMINASAEMIA 115 0.0165
417 TENDON RUPTURE 204 0.0165
418 PULMONARY MASS 246 0.0165
419 LOWER RESPIRATORY TRACT INFECTION 751 0.0165
420 FALL 5478 0.0164
421 HEPATIC STEATOSIS 306 0.0164
422 EPISTAXIS 1228 0.0164
423 DYSPNOEA 9289 0.0164
424 PNEUMOTHORAX 260 0.0164
425 OEDEMA 888 0.0164
426 EYE PRURITUS 549 0.0163
427 NIGHTMARE 563 0.0163
428 CHEST PAIN 3005 0.0162
429 INTERVERTEBRAL DISC DEGENERATION 150 0.0162
430 BLOOD SODIUM DECREASED 305 0.0162
431 KETOACIDOSIS 121 0.0162
432 FACIAL PARALYSIS 137 0.0161
433 HYPERTRIGLYCERIDAEMIA 94 0.0160
434 EMBOLISM 133 0.0160
435 SEPSIS 1784 0.0160
436 BLOOD THYROID STIMULATING HORMONE INCREASED 147 0.0160
437 HYPOALBUMINAEMIA 124 0.0159
438 HYPOTHYROIDISM 508 0.0159
439 OXYGEN SATURATION DECREASED 886 0.0157
440 CYSTITIS 502 0.0157
441 BLOOD MAGNESIUM DECREASED 136 0.0157
442 TRANSFUSION 165 0.0157
443 HAEMARTHROSIS 141 0.0157
444 DRUG-INDUCED LIVER INJURY 493 0.0157
445 DIZZINESS POSTURAL 152 0.0157
446 AORTIC ANEURYSM 119 0.0156
447 CORONARY ARTERY OCCLUSION 213 0.0155
448 ALANINE AMINOTRANSFERASE INCREASED 953 0.0155
449 DIVERTICULUM 110 0.0155
450 PNEUMONITIS 421 0.0154
451 SLEEP APNOEA SYNDROME 293 0.0153
452 NEUTROPHIL COUNT INCREASED 157 0.0153
453 HYPERTHERMIA 117 0.0153
454 GASTRITIS 403 0.0153
455 INGUINAL HERNIA 93 0.0153
456 POSTOPERATIVE WOUND INFECTION 103 0.0152
457 SINUS DISORDER 301 0.0152
458 PNEUMOCYSTIS JIROVECII PNEUMONIA 152 0.0151
459 BLOOD PRESSURE INADEQUATELY CONTROLLED 91 0.0151
460 HYPERTENSION 3200 0.0151
461 HEART RATE INCREASED 1494 0.0151
462 NEPHROTIC SYNDROME 103 0.0150
463 ERYTHEMA MULTIFORME 140 0.0150
464 BRADYPHRENIA 98 0.0150
465 PARKINSONISM 145 0.0149
466 SNEEZING 333 0.0148
467 GROIN PAIN 130 0.0148
468 LYMPHOPENIA 209 0.0148
469 CHOLECYSTITIS 176 0.0148
470 GENERAL PHYSICAL CONDITION ABNORMAL 100 0.0147
471 FEBRILE NEUTROPENIA 975 0.0147
472 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 704 0.0146
473 ACUTE RESPIRATORY FAILURE 281 0.0146
474 URINARY INCONTINENCE 431 0.0145
475 CARDIAC ARREST 1197 0.0145
476 HAEMOGLOBIN ABNORMAL 93 0.0144
477 MICTURITION URGENCY 165 0.0144
478 WRONG PRODUCT ADMINISTERED 97 0.0143
479 HAEMORRHOIDS 278 0.0142
480 BLOOD BILIRUBIN INCREASED 384 0.0142
481 HAEMOGLOBIN DECREASED 1459 0.0142
482 PLATELET COUNT INCREASED 185 0.0142
483 DEPRESSED LEVEL OF CONSCIOUSNESS 560 0.0141
484 ATRIAL SEPTAL DEFECT 118 0.0141
485 GINGIVAL BLEEDING 192 0.0140
486 MOUTH ULCERATION 295 0.0140
487 PRODUCTIVE COUGH 668 0.0140
488 HYPERCHOLESTEROLAEMIA 135 0.0140
489 ESCHERICHIA INFECTION 115 0.0140
490 BLOOD ALKALINE PHOSPHATASE INCREASED 347 0.0140
491 EXOSTOSIS 127 0.0139
492 POLYP 91 0.0139
493 PRESCRIBED UNDERDOSE 277 0.0139
494 OBESITY 221 0.0139
495 DYSURIA 508 0.0138
496 CHEST DISCOMFORT 1413 0.0138
497 EMPHYSEMA 139 0.0138
498 INTENTIONAL PRODUCT USE ISSUE 1207 0.0138
499 RENAL TUBULAR NECROSIS 135 0.0137
500 EATING DISORDER 293 0.0137
501 ACUTE HEPATIC FAILURE 188 0.0137
502 PRODUCT ADMINISTRATION ERROR 278 0.0137
503 HEPATOMEGALY 135 0.0137
504 BLOOD LACTATE DEHYDROGENASE INCREASED 217 0.0137
505 MYALGIA 2322 0.0136
506 LIVER INJURY 333 0.0136
507 COLITIS 514 0.0135
508 ULCER 215 0.0135
509 PHOTOPHOBIA 254 0.0135
510 COLD SWEAT 238 0.0135
511 PULMONARY EMBOLISM 1282 0.0135
512 WOUND 377 0.0135
513 ANAL INCONTINENCE 121 0.0134
514 TENDONITIS 207 0.0134
515 BRONCHOSPASM 190 0.0133
516 HYPERLIPIDAEMIA 159 0.0133
517 HEPATIC FAILURE 401 0.0133
518 LARGE INTESTINE PERFORATION 92 0.0132
519 PERIPHERAL SWELLING 2039 0.0132
520 CYANOSIS 208 0.0132
521 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 690 0.0132
522 LOW BIRTH WEIGHT BABY 105 0.0132
523 ABDOMINAL PAIN 3069 0.0132
524 ERECTILE DYSFUNCTION 338 0.0131
525 ASTHENIA 4943 0.0131
526 VISUAL FIELD DEFECT 95 0.0131
527 LOSS OF CONSCIOUSNESS 1680 0.0131
528 MYOCARDIAL INFARCTION 2279 0.0131
529 BLOOD IRON DECREASED 155 0.0130
530 MUCOSAL INFLAMMATION 340 0.0130
531 TENDON PAIN 98 0.0129
532 SKIN LESION 355 0.0129
533 LOW DENSITY LIPOPROTEIN INCREASED 100 0.0129
534 LUNG INFILTRATION 114 0.0129
535 APHTHOUS ULCER 100 0.0129
536 AMNESIA 837 0.0129
537 NEPHROPATHY 120 0.0128
538 PHOTOSENSITIVITY REACTION 211 0.0128
539 GASTRIC HAEMORRHAGE 147 0.0128
540 RESTLESSNESS 466 0.0127
541 TUMOUR LYSIS SYNDROME 112 0.0127
542 FLANK PAIN 119 0.0127
543 FACE OEDEMA 214 0.0127
544 POOR VENOUS ACCESS 131 0.0126
545 SEROTONIN SYNDROME 243 0.0126
546 THIRST 226 0.0126
547 DIZZINESS 6304 0.0126
548 HYPERHIDROSIS 1627 0.0126
549 HAEMATOCRIT DECREASED 250 0.0126
550 NEUTROPENIA 1712 0.0126
551 HYPOXIA 443 0.0126
552 ASPARTATE AMINOTRANSFERASE INCREASED 668 0.0126
553 PYREXIA 4335 0.0125
554 ACUTE RESPIRATORY DISTRESS SYNDROME 221 0.0125
555 LEUKOCYTOSIS 226 0.0125
556 LETHARGY 718 0.0125
557 COUGH 3472 0.0124
558 SPLENOMEGALY 145 0.0124
559 BLOOD GLUCOSE FLUCTUATION 135 0.0123
560 MUSCULOSKELETAL PAIN 644 0.0123
561 RESPIRATORY FAILURE 896 0.0123
562 CHROMATURIA 277 0.0123
563 ILEUS 152 0.0122
564 CYTOKINE RELEASE SYNDROME 245 0.0122
565 PNEUMONIA 3940 0.0122
566 RHINORRHOEA 782 0.0121
567 ARTHRITIS 950 0.0121
568 DYSPHAGIA 1145 0.0121
569 PROTEINURIA 229 0.0120
570 DIARRHOEA HAEMORRHAGIC 112 0.0120
571 BLOOD PRESSURE ABNORMAL 238 0.0120
572 CHOLELITHIASIS 392 0.0119
573 COAGULOPATHY 199 0.0119
574 LYMPHOCYTE COUNT DECREASED 210 0.0119
575 BLOOD ALBUMIN DECREASED 94 0.0118
576 THROMBOTIC MICROANGIOPATHY 115 0.0118
577 BRAIN OEDEMA 149 0.0118
578 UNRESPONSIVE TO STIMULI 301 0.0117
579 CARDIOTOXICITY 104 0.0116
580 SYNOVITIS 210 0.0116
581 HEAD INJURY 368 0.0116
582 ACCIDENTAL OVERDOSE 424 0.0116
583 MIOSIS 93 0.0116
584 HICCUPS 95 0.0116
585 STEVENS-JOHNSON SYNDROME 257 0.0115
586 DERMATITIS ALLERGIC 145 0.0115
587 SPINAL PAIN 135 0.0115
588 DEVICE RELATED INFECTION 177 0.0115
589 NEUROLEPTIC MALIGNANT SYNDROME 136 0.0115
590 INCONTINENCE 121 0.0114
591 FREQUENT BOWEL MOVEMENTS 309 0.0114
592 HYPOPHAGIA 292 0.0114
593 FRACTURE 216 0.0114
594 MUSCLE ATROPHY 144 0.0114
595 MALAISE 4978 0.0113
596 CARDIAC FAILURE CONGESTIVE 911 0.0113
597 IMPAIRED QUALITY OF LIFE 163 0.0113
598 MULTI-ORGAN FAILURE 196 0.0113
599 LUNG DISORDER 553 0.0113
600 CARDIAC DISORDER 1055 0.0113
601 BODY TEMPERATURE INCREASED 230 0.0113
602 ENCEPHALOPATHY 275 0.0112
603 URINARY TRACT INFECTION 1907 0.0112
604 DECREASED APPETITE 2588 0.0111
605 SINUS TACHYCARDIA 158 0.0111
606 INFLAMMATION 573 0.0111
607 HEPATIC FUNCTION ABNORMAL 412 0.0110
608 SALIVARY HYPERSECRETION 110 0.0110
609 PERSONALITY CHANGE 102 0.0110
610 WOUND INFECTION 120 0.0109
611 FEELING COLD 304 0.0109
612 INTENTIONAL OVERDOSE 700 0.0109
613 LIVER FUNCTION TEST INCREASED 234 0.0109
614 PARAESTHESIA ORAL 157 0.0109
615 ECZEMA 569 0.0109
616 VOMITING 5106 0.0108
617 ORAL CANDIDIASIS 143 0.0108
618 ANAPHYLACTIC SHOCK 280 0.0108
619 SQUAMOUS CELL CARCINOMA 102 0.0108
620 CARDIOVASCULAR DISORDER 275 0.0108
621 DRUG INTOLERANCE 1042 0.0108
622 PULMONARY ARTERIAL HYPERTENSION 156 0.0108
623 WHITE BLOOD CELL COUNT INCREASED 412 0.0107
624 OROPHARYNGEAL DISCOMFORT 97 0.0107
625 RED BLOOD CELL COUNT DECREASED 307 0.0107
626 POST PROCEDURAL HAEMORRHAGE 125 0.0107
627 BLOOD GLUCOSE ABNORMAL 198 0.0107
628 HAEMOLYTIC ANAEMIA 96 0.0107
629 APATHY 156 0.0107
630 OSTEOARTHRITIS 453 0.0107
631 HYPOTONIA 106 0.0106
632 RESPIRATORY DISTRESS 292 0.0106
633 METASTASES TO LUNG 122 0.0105
634 CHRONIC KIDNEY DISEASE 802 0.0105
635 HEPATOTOXICITY 235 0.0105
636 ABDOMINAL PAIN LOWER 266 0.0105
637 DIARRHOEA 6775 0.0105
638 SOMNOLENCE 2113 0.0105
639 BLOOD CALCIUM DECREASED 118 0.0105
640 ABSCESS 167 0.0105
641 ATELECTASIS 101 0.0104
642 CATARACT 622 0.0104
643 BLOOD TRIGLYCERIDES INCREASED 184 0.0104
644 SKIN LACERATION 113 0.0104
645 JOINT SWELLING 1254 0.0104
646 EPILEPSY 317 0.0104
647 TYPE 2 DIABETES MELLITUS 349 0.0104
648 NEPHROPATHY TOXIC 116 0.0103
649 GLYCOSYLATED HAEMOGLOBIN INCREASED 260 0.0103
650 VISUAL IMPAIRMENT 1276 0.0103
651 NEURALGIA 250 0.0103
652 DEEP VEIN THROMBOSIS 665 0.0102
653 BACTERAEMIA 121 0.0102
654 POLLAKIURIA 425 0.0102
655 MUSCULOSKELETAL STIFFNESS 888 0.0101
656 CONDITION AGGRAVATED 3074 0.0101
657 LIVER DISORDER 447 0.0101
658 BALANCE DISORDER 871 0.0101
659 COVID-19 1755 0.0100
660 DRUG PRESCRIBING ERROR 192 0.0100
661 DEAFNESS 261 0.0100
662 TOXICITY TO VARIOUS AGENTS 1683 0.0100
663 BLOOD URINE PRESENT 189 0.0099
664 DIABETIC KETOACIDOSIS 239 0.0099
665 CONTUSION 953 0.0099
666 CELLULITIS 496 0.0098
667 MUSCULOSKELETAL CHEST PAIN 151 0.0097
668 JOINT DISLOCATION 103 0.0097
669 CEREBROVASCULAR ACCIDENT 1646 0.0097
670 CLOSTRIDIUM DIFFICILE INFECTION 212 0.0097
671 DRY MOUTH 788 0.0097
672 COLITIS ULCERATIVE 434 0.0097
673 BRAIN INJURY 97 0.0097
674 DIVERTICULITIS 268 0.0097
675 DEPRESSED MOOD 511 0.0097
676 INTENTIONAL PRODUCT MISUSE 846 0.0097
677 DISSEMINATED INTRAVASCULAR COAGULATION 136 0.0097
678 SKIN REACTION 136 0.0096
679 HEPATIC ENZYME INCREASED 657 0.0096
680 RASH PRURITIC 522 0.0096
681 RIB FRACTURE 198 0.0096
682 SUICIDE ATTEMPT 582 0.0096
683 BACK PAIN 2229 0.0096
684 CARPAL TUNNEL SYNDROME 134 0.0096
685 ABDOMINAL PAIN UPPER 1968 0.0095
686 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 678 0.0095
687 EYE PAIN 537 0.0095
688 BONE MARROW FAILURE 193 0.0095
689 FLUID OVERLOAD 138 0.0095
690 RESTLESS LEGS SYNDROME 172 0.0094
691 HEPATIC CIRRHOSIS 177 0.0094
692 CHILLS 1102 0.0094
693 AGITATION 690 0.0094
694 DIABETES MELLITUS 716 0.0094
695 ARTHRALGIA 3879 0.0093
696 FATIGUE 7263 0.0093
697 CYTOMEGALOVIRUS INFECTION 155 0.0093
698 ASPIRATION 101 0.0092
699 WEIGHT DECREASED 2555 0.0091
700 EYELID PTOSIS 93 0.0091
701 METASTASES TO LIVER 160 0.0091
702 RENAL PAIN 96 0.0090
703 GASTROINTESTINAL DISORDER 811 0.0090
704 SENSORY DISTURBANCE 145 0.0090
705 MUSCLE RIGIDITY 108 0.0090
706 MALNUTRITION 101 0.0090
707 MYELODYSPLASTIC SYNDROME 129 0.0089
708 MALIGNANT MELANOMA 119 0.0089
709 SLEEP DISORDER 626 0.0089
710 MOBILITY DECREASED 636 0.0088
711 PAIN IN EXTREMITY 2606 0.0088
712 NEUROTOXICITY 154 0.0088
713 METASTASES TO BONE 144 0.0088
714 DYSPHONIA 513 0.0088
715 RESPIRATORY DISORDER 262 0.0087
716 GAIT DISTURBANCE 1669 0.0087
717 CONSTIPATION 1874 0.0086
718 SPEECH DISORDER 450 0.0086
719 ABDOMINAL DISCOMFORT 1435 0.0085
720 FLUID RETENTION 434 0.0085
721 LOCALISED INFECTION 206 0.0085
722 IMPAIRED HEALING 278 0.0085
723 SWELLING FACE 551 0.0085
724 BLOOD POTASSIUM DECREASED 254 0.0084
725 DELUSION 131 0.0084
726 SCHIZOPHRENIA 102 0.0084
727 MIGRAINE 801 0.0084
728 FOOT DEFORMITY 93 0.0084
729 METASTASES TO CENTRAL NERVOUS SYSTEM 108 0.0084
730 HALLUCINATION, AUDITORY 133 0.0084
731 INSOMNIA 2221 0.0083
732 PSYCHOMOTOR HYPERACTIVITY 138 0.0083
733 SKIN INFECTION 93 0.0083
734 MOVEMENT DISORDER 266 0.0083
735 IMPAIRED WORK ABILITY 177 0.0083
736 BLOOD COUNT ABNORMAL 125 0.0082
737 NAUSEA 6519 0.0082
738 GASTROOESOPHAGEAL REFLUX DISEASE 663 0.0082
739 ERYTHEMA 1691 0.0082
740 NECK PAIN 458 0.0082
741 CANDIDA INFECTION 137 0.0081
742 STAPHYLOCOCCAL INFECTION 267 0.0081
743 BRONCHITIS 598 0.0081
744 BURSITIS 98 0.0081
745 ANAPHYLACTIC REACTION 446 0.0081
746 DYSPEPSIA 793 0.0081
747 NEUTROPHIL COUNT DECREASED 328 0.0080
748 ABDOMINAL DISTENSION 840 0.0080
749 MUSCLE SPASMS 1473 0.0080
750 OSTEONECROSIS OF JAW 198 0.0080
751 RHEUMATOID ARTHRITIS 906 0.0080
752 PRURITUS 3058 0.0079
753 TASTE DISORDER 161 0.0079
754 LIMB DISCOMFORT 245 0.0079
755 RASH MACULAR 275 0.0079
756 ERUCTATION 152 0.0078
757 OSTEOPOROSIS 322 0.0078
758 ACUTE MYELOID LEUKAEMIA 122 0.0078
759 INTERVERTEBRAL DISC PROTRUSION 171 0.0078
760 PRODUCT DISPENSING ERROR 170 0.0078
761 INFUSION RELATED REACTION 516 0.0078
762 FLATULENCE 441 0.0078
763 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 181 0.0078
764 INFECTION 1117 0.0077
765 LYMPHADENOPATHY 273 0.0077
766 DYSKINESIA 313 0.0077
767 MEMORY IMPAIRMENT 1056 0.0077
768 HYPOAESTHESIA 1146 0.0076
769 MASS 107 0.0076
770 INFLUENZA 853 0.0076
771 ASTHMA 863 0.0076
772 CHOKING 148 0.0076
773 RENAL DISORDER 353 0.0076
774 CENTRAL NERVOUS SYSTEM LESION 104 0.0076
775 GENERALISED TONIC-CLONIC SEIZURE 124 0.0075
776 PANCREATITIS 395 0.0075
777 HAEMORRHAGE 781 0.0075
778 BLISTER 419 0.0075
779 AGGRESSION 368 0.0073
780 ANXIETY 2092 0.0073
781 OSTEOMYELITIS 133 0.0073
782 RASH ERYTHEMATOUS 351 0.0073
783 SEDATION 192 0.0073
784 PLATELET COUNT DECREASED 780 0.0073
785 PANIC ATTACK 266 0.0073
786 LIMB INJURY 198 0.0073
787 ARTHROPATHY 405 0.0073
788 DERMATITIS 152 0.0072
789 PARANOIA 125 0.0072
790 BONE PAIN 424 0.0072
791 HEADACHE 4538 0.0072
792 INTESTINAL OBSTRUCTION 272 0.0072
793 PREMATURE BABY 217 0.0072
794 SARS-COV-2 TEST POSITIVE 95 0.0072
795 TREMOR 1193 0.0072
796 SYSTEMIC LUPUS ERYTHEMATOSUS 255 0.0072
797 COLON CANCER 107 0.0072
798 CONJUNCTIVITIS 133 0.0072
799 TOOTHACHE 129 0.0071
800 SKIN EXFOLIATION 600 0.0071
801 HERPES ZOSTER 407 0.0071
802 LUNG INFECTION 110 0.0071
803 PRESCRIBED OVERDOSE 137 0.0071
804 ORAL PAIN 158 0.0070
805 MALIGNANT NEOPLASM PROGRESSION 722 0.0070
806 PROSTATIC SPECIFIC ANTIGEN INCREASED 97 0.0070
807 TREATMENT NONCOMPLIANCE 383 0.0070
808 DYSSTASIA 204 0.0070
809 PARAESTHESIA 1098 0.0070
810 LACRIMATION INCREASED 210 0.0069
811 PERITONITIS 142 0.0068
812 VISION BLURRED 940 0.0068
813 POOR QUALITY SLEEP 147 0.0068
814 NASOPHARYNGITIS 1258 0.0068
815 INFLUENZA LIKE ILLNESS 561 0.0068
816 JOINT STIFFNESS 178 0.0068
817 FEELING HOT 414 0.0067
818 PAIN IN JAW 191 0.0067
819 WEIGHT INCREASED 1508 0.0067
820 PARALYSIS 96 0.0067
821 KIDNEY INFECTION 131 0.0067
822 OFF LABEL USE 5812 0.0066
823 OROPHARYNGEAL PAIN 612 0.0066
824 THERAPY PARTIAL RESPONDER 103 0.0066
825 DISCOMFORT 402 0.0066
826 BLOOD CHOLESTEROL INCREASED 307 0.0066
827 EAR PAIN 128 0.0066
828 RASH GENERALISED 169 0.0065
829 FEEDING DISORDER 132 0.0065
830 SPINAL FRACTURE 130 0.0065
831 SCIATICA 103 0.0065
832 PHARYNGEAL OEDEMA 99 0.0064
833 BLOOD GLUCOSE INCREASED 1212 0.0064
834 THYROID DISORDER 99 0.0064
835 JOINT INJURY 137 0.0064
836 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 108 0.0064
837 SKIN DISORDER 211 0.0063
838 DEMENTIA 176 0.0063
839 PRURITUS GENERALISED 136 0.0063
840 FOETAL EXPOSURE DURING PREGNANCY 510 0.0063
841 SEIZURE 720 0.0062
842 SKIN DISCOLOURATION 286 0.0062
843 LYMPHOMA 96 0.0062
844 STOMATITIS 374 0.0062
845 HYPOACUSIS 265 0.0061
846 DRY SKIN 820 0.0061
847 MENTAL IMPAIRMENT 148 0.0061
848 GAIT INABILITY 204 0.0061
849 DYSGEUSIA 453 0.0061
850 PAIN 3736 0.0061
851 BACTERIAL INFECTION 113 0.0061
852 RASH 2640 0.0061
853 ALOPECIA 1178 0.0060
854 NIGHT SWEATS 193 0.0060
855 END STAGE RENAL DISEASE 109 0.0060
856 NEUROPATHY PERIPHERAL 566 0.0059
857 AGEUSIA 148 0.0059
858 DEPRESSION 1346 0.0059
859 FEMUR FRACTURE 183 0.0059
860 HERNIA 113 0.0058
861 MIDDLE INSOMNIA 109 0.0058
862 EXTRAPYRAMIDAL DISORDER 144 0.0058
863 BURNING SENSATION 404 0.0058
864 SKIN CANCER 123 0.0057
865 HOT FLUSH 430 0.0057
866 FEELING ABNORMAL 1363 0.0057
867 RETCHING 121 0.0057
868 THROAT TIGHTNESS 153 0.0057
869 THERAPY NON-RESPONDER 254 0.0056
870 THROMBOSIS 454 0.0056
871 MUSCULOSKELETAL DISCOMFORT 97 0.0056
872 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1010 0.0056
873 VIRAL INFECTION 186 0.0056
874 LUNG NEOPLASM MALIGNANT 229 0.0056
875 OVERDOSE 1195 0.0055
876 INTENTIONAL SELF-INJURY 111 0.0055
877 HYPERSENSITIVITY 1019 0.0055
878 MENTAL DISORDER 238 0.0055
879 MUSCULOSKELETAL DISORDER 104 0.0055
880 NEPHROLITHIASIS 250 0.0054
881 PSORIATIC ARTHROPATHY 221 0.0054
882 PRODUCT USE IN UNAPPROVED INDICATION 1340 0.0054
883 SWELLING 506 0.0054
884 NEOPLASM PROGRESSION 187 0.0054
885 UPPER LIMB FRACTURE 106 0.0053
886 DISEASE PROGRESSION 628 0.0053
887 DRUG ABUSE 441 0.0053
888 PSYCHOTIC DISORDER 154 0.0052
889 THROAT IRRITATION 233 0.0052
890 SUICIDAL IDEATION 472 0.0052
891 VISUAL ACUITY REDUCED 171 0.0051
892 THERAPEUTIC PRODUCT EFFECT DECREASED 228 0.0051
893 ADVERSE DRUG REACTION 457 0.0051
894 SINUSITIS 521 0.0051
895 PLASMA CELL MYELOMA 198 0.0051
896 WHITE BLOOD CELL COUNT DECREASED 548 0.0051
897 NASAL CONGESTION 295 0.0050
898 HIP FRACTURE 158 0.0049
899 SKIN FISSURES 95 0.0049
900 PSORIASIS 630 0.0048
901 URTICARIA 802 0.0048
902 EYE DISORDER 157 0.0048
903 NERVOUS SYSTEM DISORDER 149 0.0048
904 IRRITABLE BOWEL SYNDROME 102 0.0048
905 POST PROCEDURAL COMPLICATION 91 0.0047
906 TOOTH DISORDER 105 0.0047
907 DISEASE RECURRENCE 223 0.0047
908 NEEDLE ISSUE 136 0.0047
909 ORAL HERPES 91 0.0047
910 FIBROMYALGIA 113 0.0046
911 MOOD ALTERED 126 0.0046
912 EYE SWELLING 171 0.0046
913 DRY EYE 229 0.0046
914 THERAPEUTIC RESPONSE DECREASED 278 0.0046
915 FUNGAL INFECTION 151 0.0045
916 GASTRIC DISORDER 152 0.0044
917 UPPER RESPIRATORY TRACT INFECTION 203 0.0044
918 EAR INFECTION 116 0.0044
919 PRODUCT AVAILABILITY ISSUE 99 0.0043
920 HYPERSOMNIA 124 0.0043
921 RESPIRATORY ARREST 118 0.0043
922 UNDERDOSE 311 0.0043
923 INCORRECT PRODUCT ADMINISTRATION DURATION 92 0.0042
924 NERVOUSNESS 221 0.0042
925 TREATMENT FAILURE 348 0.0042
926 PRODUCT SUBSTITUTION ISSUE 241 0.0042
927 DEVICE DISLOCATION 181 0.0042
928 LABORATORY TEST ABNORMAL 122 0.0041
929 GYNAECOMASTIA 122 0.0039
930 DRUG RESISTANCE 101 0.0039
931 OSTEONECROSIS 128 0.0039
932 PRODUCT USE ISSUE 727 0.0039
933 OCULAR HYPERAEMIA 183 0.0039
934 FLUSHING 385 0.0038
935 ILL-DEFINED DISORDER 228 0.0037
936 DRUG INEFFECTIVE 4872 0.0037
937 INTENTIONAL DOSE OMISSION 105 0.0037
938 FEAR 99 0.0037
939 MENTAL STATUS CHANGES 102 0.0037
940 ABNORMAL BEHAVIOUR 142 0.0036
941 ABNORMAL DREAMS 97 0.0035
942 DRUG ADMINISTRATION ERROR 104 0.0034
943 WITHDRAWAL SYNDROME 140 0.0033
944 MATERNAL EXPOSURE DURING PREGNANCY 296 0.0033
945 BLOOD GLUCOSE DECREASED 159 0.0033
946 DEATH 2848 0.0033
947 ROAD TRAFFIC ACCIDENT 138 0.0033
948 ILLNESS 333 0.0032
949 MOOD SWINGS 102 0.0032
950 IRRITABILITY 191 0.0032
951 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 170 0.0031
952 INJECTION SITE MASS 113 0.0031
953 ANGER 103 0.0030
954 ADVERSE EVENT 266 0.0029
955 INJURY 191 0.0027
956 NEOPLASM MALIGNANT 181 0.0027
957 HOSPITALISATION 402 0.0026
958 CONVULSION 148 0.0026
959 CRYING 93 0.0026
960 INCORRECT DOSE ADMINISTERED 581 0.0025
961 MULTIPLE SCLEROSIS RELAPSE 167 0.0024
962 EXPOSURE DURING PREGNANCY 147 0.0024
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 476 0.0023
964 SKIN IRRITATION 104 0.0023
965 VAGINAL HAEMORRHAGE 96 0.0022
966 PROSTATE CANCER 176 0.0022
967 SURGERY 121 0.0021
968 DEVICE MALFUNCTION 140 0.0020
969 EYE IRRITATION 112 0.0019
970 THERAPY CESSATION 99 0.0019
971 UNEVALUABLE EVENT 143 0.0019
972 BREAST CANCER 174 0.0019
973 BLADDER CANCER 108 0.0018
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 130 0.0018
975 THERAPY INTERRUPTED 128 0.0018
976 PRODUCT DOSE OMISSION ISSUE 523 0.0018
977 ACNE 130 0.0017
978 PRODUCT DOSE OMISSION 106 0.0016
979 COMPLETED SUICIDE 129 0.0015
980 PRODUCT STORAGE ERROR 130 0.0015
981 INJECTION SITE SWELLING 112 0.0015
982 INJECTION SITE BRUISING 113 0.0014
983 SKIN BURNING SENSATION 101 0.0014
984 EMOTIONAL DISTRESS 168 0.0014
985 INJECTION SITE PAIN 421 0.0014
986 INJECTION SITE HAEMORRHAGE 109 0.0014
987 DEVICE ISSUE 105 0.0012
988 INJECTION SITE ERYTHEMA 128 0.0010
989 PRODUCT QUALITY ISSUE 132 0.0010
990 DRUG DOSE OMISSION 138 0.0008
991 NO ADVERSE EVENT 143 0.0008
992 DRUG DEPENDENCE 98 0.0006